Log in
Enquire now
‌

US Patent 8257740 Pharmaceutical composition of nanoparticles

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8257740
Patent Inventor Names
Kiran Sonaje0
Hsing-Wen Sung0
Ho-Ngoc Nguyen0
Hosheng Tu0
Date of Patent
September 4, 2012
Patent Application Number
13136912
Date Filed
August 15, 2011
Patent Citations Received
‌
US Patent 12084516 Anti-C5 antibody combinations and uses thereof
0
‌
US Patent 11773156 Anti-hemagglutinin antibodies and methods of use thereof
‌
US Patent 11780907 Human antibodies to influenza hemagglutinin
‌
US Patent 11884736 Antibodies which bind to glucagon-like peptide 1 receptor (GLP1R)
0
‌
US Patent 11932692 Methods of treating cancer pain by administering a PD-1 inhibitor
0
‌
US Patent 11945872 Anti-ACVR1 antibodies and uses thereof
0
‌
US Patent 12024556 Anti-
0
0
...
Patent Primary Examiner
‌
Maryam Monshipouri
Patent abstract

The invention discloses a composition of chitosan-shelled nanoparticles and methods of manufacturing. The chitosan-shelled nanoparticles are characterized with a positive surface charge and enhanced epithelial ermeability for oral drug delivery.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8257740 Pharmaceutical composition of nanoparticles

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.